France Respiratory Drug Market Trends, Size, Competitive Analysis and Forecast 2019-2025
France respiratory drug market was valued more than $1.3 billion in 2018 and is anticipated to grow at a substantial rate of 6.0% during the forecast period. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors augmenting the growth of the respiratory drug market in the country. Moreover, the presence of market players in the country is also influencing the market growth of the country. For instance, Air Liquide S.A., in April 2018, acquired a French start-up company EOVE for the extension of service offering of home healthcare activities. In January 2018, the company acquired the respiratory division of Thimar Al Jazirah Company (TAC) for geographical expansion and enter into the Saudi Arabia market. In September 2017, Air Liquide acquired Sogo Sangyo Kabushiki Kaisha for expanding its healthcare business in Japan.
To Request a Sample of our Report on France
Respiratory Drug Market: https://www.omrglobal.com/request-sample/france-respiratory-drug-market
The France respiratory drug market
is segmented on the basis of the route of administration, application, and
end-user. Based on the route of administration, the market is classified into
oral, injectable, and inhalable. Moreover, on the basis of application, the
market has been classified into asthma and COPD diseases. The asthma disease
application segment dominated the regional market in 2018 and is further
estimated to follow the same trend over the forecast period. This is mainly due
to the high prevalence of asthma in the country. In addition, based on the
end-user, homecare and hospitals and clinics have been analyzed.
(Get 15% Discount on Buying this Report)
A
full Report of France Respiratory Drug Market is Available @ https://www.omrglobal.com/industry-reports/france-respiratory-drug-market
France Respiratory Drug Market Segmentation
By Route of Administration
·
Oral
·
Injectable
·
Inhalable
·
France Respiratory Drug Market by Application
·
Asthma
·
Chronic Obstructive Pulmonary Disease (COPD)
By End-User
·
Homecare
·
Hospitals and Clinics
Company Profiles
·
Air Liquide S.A.
·
Aradigm Corp.
·
AstraZeneca PLC
·
Baxter International Inc.
·
Boehringer Ingelheim International GmbH
·
F. Hoffmann-La Roche Ltd.
·
GlaxoSmithKline PLC
·
Merck & Co.
·
Novartis AG
·
Omron Healthcare Inc.
·
Pfizer Inc.
·
Pulmatrix Inc.
·
ResMed Corp.
·
Savara, Inc.
·
unovion Pharmaceuticals
·
Takeda Pharmaceutical Company Ltd.
·
Teva Pharmaceuticals Industries Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment